Efficacy and safety of multiple doses of tapentadol oral solution in the treatment of moderate to severe acute pain in children aged 2 to <18 years – a randomized, double-blind, placebo-controlled trial

BACKGROUND: Well-controlled trials of analgesics in the pediatric population are scarce. Tapentadol is a strong centrally acting analgesic which has undergone a pediatric development program investigating its suitability for treating moderate to severe acute pain across the entire pediatric age rang...

Descripción completa

Detalles Bibliográficos
Autores principales: Beuter, Christoph, Volkers, Gisela, Radic, Tatjana, Goldberg, Jutta, van den Anker, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859087/
https://www.ncbi.nlm.nih.gov/pubmed/32009813
http://dx.doi.org/10.2147/JPR.S207010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859087/
https://www.ncbi.nlm.nih.gov/pubmed/32009813
http://dx.doi.org/10.2147/JPR.S207010

Ejemplares similares